Transient Hypoxia Alters Striatal Catecholamine Metabolism in Immature Brain: An In Vivo Microdialysis Study by Gordon, Kevin et al.
Journal of Neurochemistry 
Raven Press, Ltd., New York 
0 1990 International Society for Neurochemistry 
Transient Hypoxia Alters Striatal Catecholamine Metabolism 
in Immature Brain: An In Vivo Microdialysis Study 
*?Kevin Gordon, *tDaniel Statman, *-/=Michael V. Johnston, $Terry E. Robinson, 
+Jill B. Becker, and *?Faye S. Silverstein 
Departments of *Pediatrics, TNeurology, and *Psychology, University of Michigan, Ann Arbor, Michigan, U S A .  
Abstract: Microdialysis probes were inserted bilaterally into 
the striatum of 7-day-old rat pups (n = 30) to examine ex- 
tracellular fluid levels of dopamine, its metabolites 3,4-dihy- 
droxyphenylacetic acid (DOPAC) and homovanillic acid 
(HVA), and the serotonin metabolite 5-hydroxyindoleacetic 
acid (5-HIAA). The dialysis samples were assayed by HPLC 
with electrochemical detection. Baseline levels, measured after 
a 2-h stabilization period, were as follows: dopamine, not 
detected; DOPAC, 6 17 f 33 fmol/min; HVA, 974 f 42 fmol/ 
min; and 5-HIAA, 276 5 15 fmol/min. After a 40-min base- 
line sampling period, 12 animals were exposed to 8% oxygen 
for 120 min. Hypoxia produced marked reductions in the 
striatal extracellular fluid levels of both dopamine metabolites 
( p  < 0.001 by analysis of variance) and a more gradual and 
less prominent reduction in 5-HIAA levels ( p  < 0.02 by anal- 
ysis of variance), compared with controls (n = 12) sampled 
~ ~~ 
in room air. In the first hour after hypoxia, DOPAC and 
HVA levels rose quickly, whereas 5-HIAA levels remained 
suppressed. The magnitude of depolarization-evoked release 
of dopamine (elicited by infusion of potassium or veratrine 
through the microdialysis probes for 20 min) was evaluated 
in control and hypoxic animals. Depolarization-evoked do- 
pamine efflux was considerably higher in hypoxic pups than 
in controls: hypoxic (n = 7), 257 k 32 fmol/min; control (n 
= 12), 7 5 f 14 fmol/min ( p  < 0.00 1 by analysis of variance). 
These data demonstrate that a brief exposure to moderate 
hypoxia markedly disrupts striatal catecholamine metabolism 
in the immature rodent brain. Key Words: Dopamine-Mi- 
crodialysis-Striatum-Immature brain-Hypoxia. Gordon 
K. et al. Transient hypoxia alters striatal catecholamine me- 
tabolism in immature brain: An in vivo microdialysis study. 
J. Neurochem. 54, 605-6 1 1 ( 1990). 
In the perinatal period, infants with various clinical 
disorders are commonly exposed to brief, as well as 
more prolonged, periods of hypoxia. The immature 
brain is considered to be relatively resistant to neuro- 
pathologic damage from moderate hypoxia, and it is 
uncertain if moderate hypoxia, e.g., PAoz of 25-50 torr, 
alone can produce either acute behavioral changes or 
long-term adverse neurodevelopmental sequelae. Nev- 
ertheless, exposure to moderate hypoxia during early 
postnatal life, which does not cause neuronal damage, 
may disrupt functional activity at selected synapses in 
experimental animals (Hedner and Lundborg, 1979, 
1980). Furthermore, there is evidence that exposure to 
hypoxia at critical stages in development may cause 
permanent changes in synaptic function (Ihle et al., 
1985; Lun et al., 1986). 
Studies in mature animals indicate that dopami- 
nergic neurons are susceptible to functional disruption 
by moderate hypoxia (Davis and Carlsson, 1973; Miwa 
et al., 1986). Less is known about the effects of hypoxia 
on developing dopaminergic neurons, but the 7-day- 
old rat has a potentially functional dopaminergic in- 
nervation in the striatum. In addition, we reported 
previously that hypoxia transiently suppressed both 
tissue concentrations of the dopamine metabolite ho- 
movanillic acid (HVA) and dopamine uptake into 
striatal tissue prepared from immature rodent brain 
(Silverstein and Johnston, 1984; Silverstein et al., 
1986). 
In this study, we used in vivo microdialysis to ex- 
amine the effects of hypoxia on dopamine metabolism 
more directly, by measuring striatal extracellular fluid 
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(ECF) concentrations of dopamine and its metabolites 
as well as of the serotonin metabolite 5-hydroxyindole- 
acetic acid ( 5 - H I M )  before, during, and after exposure 
to 8% oxygen. In addition, we evaluated changes in 
depolarization-induced dopamine release and striatal 
tissue concentrations of dopamine after hypoxic ex- 
posure. 
We  found that hypoxic exposure resulted in marked 
suppression of striatal ECF levels of the dopamine me- 
tabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and 
HVA and a more gradual and less prominent reduction 
in levels of the serotonin metabolite 5-HIAA. After the 
end of hypoxic exposure, DOPAC and HVA levels rose 
quickly, whereas 5-HIAA levels remained suppressed. 
In addition, the magnitude of depolarization-evoked 
dopamine release (elicited by infusion of potassium or 
veratrine) was considerably higher in hypoxic pups than 
in controls, and there was a corresponding elevation 
in striatal dopamine concentrations measured in post- 
mortem tissue. 
MATERIALS AND METHODS 
Experimental design 
Microdialysis probes were implanted bilaterally into the 
striatum of 7-day-old male Sprague-Dawley rat pups (n 
= 54). Subsequent histological examination (see below) ver- 
ified accurate, symmetrical probe placement in 30 pups (57%), 
and only data from these pups are presented. The protocol 
included (a) probe insertion and stabilization (210 rnin); (b) 
microdialysis sampling over 20-min intervals during the three 
sequential periods of baseline (40 min), experimental (1 60 
min), and recovery (60 rnin); and (c) assay of depolarization- 
evoked dopamine release by infusion of depolarizing agents 
( 100 mMK+ or 100 pg/ml of veratrine) over a 20-min period 
at the end of the baseline and experimental periods. From 
animals that received infusions of depolarizing drugs, no 
subsequent samples were obtained. Results from two addi- 
tional pups were included in a single component of this study, 
analysis of depolarization-evoked dopamine release after 
hypoxic exposure. 
During the experimental period, animals were exposed to 
8% oxygen (n = 12) or room air (n = 12). Previously, we 
found that in awake 7-day-old rat pups, exposure to 8% ox- 
ygen results in an abrupt and sustained decline in arterial 
oxygen content (PAo2, 30 torr) and concurrently elicits hy- 
perventilation (PAco2, 25 torr) (Silverstein and Johnston, 
1984). This degree of hypoxia does not result in global energy 
failure in brain (Welsh et al., 1982) but is of sufficient con- 
sequence to suppress striatal high-affinity dopamine uptake 
(Silverstein et al., 1986). To evaluate depolarization-evoked 
ECF dopamine eWux, control pups received either 100 mM 
K+ (n = 3) or 100 pg/ml of veratrine (n = 3) after the baseline 
period, and another sample was obtained. At the end of the 
experimental period, hypoxic pups (n = 7) were perfused 
with either 100 mM K+ (n = 2) or 100 &ml of veratrine (n 
= 5) for 20 min, and a final sample was obtained. The control 
animals received infusions of K+ (n = 3) or veratrine (n 
= 3) during this same interval. Of note was that 100 mM K+ 
was infused to ensure that the K+ concentrations achieved 
in brain were adequate to induce depolarization; K+ concen- 
trations in brain were probably considerably lower because 
FIG. 1. Illustration of the sites of bilateral probe placement. The 
sites of probe insertion are superimposed on a coronal brain section 
from a 7-day-old rat, at the level of striatum. 
of the rate of diffusion through the probe membrane as well 
as dilution by the ECF. 
Microdialysis probe design 
The microdialysis probe design was a modification of that 
described previously by Robinson and Whishaw (1988). The 
probes had a concentric design with a 2-mm-long dialyzing 
membrane (outside diameter, 250 pm; molecular-weight 
cutoff, 6,000; Spectra/Por; Spectrum Medical). Microdialysis 
probe efficiency was calculated for each of the compounds 
detected in vitro at 37°C using the average of two samples 
(Ungerstedt, 1984). The relative recovery values obtained 
(mean k SEM, n = 60) were as follows: dopamine, 21.6 
& 0.5%; DOPAC, 21.3 k 0.4%; HVA, 20 k 0.4%; and 5- 
HIAA, 21.8 ? 0.5%. 
Two microdialysis probes were placed in a rigid plastic 
mounting system that could be readily affixed to the skull 
surface (Fig. 1). The mounting system was constructed from 
a plastic slide holder with two parallel channels (2 mm wide, 
3 mm deep, and 5 mm apart). The mounting surface was 
carved concave to conform to the shape of the skull and was 
then cut in half. The microdialysis probes were glued (Devcon 
5 Minute Epoxy) to the upper section. 
Microdialysis probe insertion 
Rat pups were anesthetized with ether. An oval scalp flap 
16 mm (anteroposterior) by 9 mm (lateral), centered on 
bregma, was excised. Pups were then left under a heating 
lamp and a stream of warm air for 90 rnin to dry the skull 
surface, thus ensuring adhesion of the microdialysis probe 
mount to the skull. The pups were then reanesthetized with 
ether and placed in a stereotaxic frame. The concave section 
of the probe mount was aligned at bregma and attached to 
the skull with cyanoacrylate glue (Superglue). Bilateral cranial 
flaps (2 X 2 mm) were removed at the base of the channels 
of the lower probe mount. The upper section of the probe 
mount holding the two parallel microdialysis probes was then 
lowered with stereotactic guidance, allowing simultaneous 
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implantation of the microdialysis probes into striatum when 
the two sections of the probe mount met. The two sections 
of the probe mount were reattached with cyanoacrylate glue 
(Superglue). The exposed skull surface and the edges of the 
lower probe mount were coated with a thin layer of epoxy 
(Devcon 5 Minute). The final position of the microdialysis 
membrane was 1 mm posterior and 2.5 mm lateral to bregma 
and 3-5 mm from the skull surface (Fig. I ) .  The implantation 
of the probes was completed within 5 min. Pups were then 
placed in a plastic chamber heated in a 34°C water bath. 
At the end of each experiment, pups were killed by de- 
capitation, and brains were quickly removed and placed in 
formalin. Microdialysis probe placement was subsequently 
verified by examination of horizontal brain sections. Blood 
glucose levels, measured by Dextrostix on blood obtained 
from the carotid arteries, were normal in all pups. 
Sample collection 
Microdialysis probes were perfused with filtered modified 
Ringer’s solution (147.2 mmol of Na’, 4.0 mmol of K’, 3.4 
mmol of Ca”, and 154.6 mmol of C1-, pH 6.0) at 1.5 pl /  
min using a microinfusion pump (CMA 100; BAS). 
No samples were collected for the first 120 rnin after im- 
plantation. Samples were then collected on ice over successive 
20-min intervals. The first two samples (baseline period; 40 
min j were used to estimate baseline ECF neurotransmitter 
and metabolite levels. During the next seven samples (ex- 
perimental period 140 rnin), animals were exposed to control 
or hypoxic conditions. The three final samples were obtained 
in room air (recovery period; 60 rnin). 
In animals exposed to hypoxic conditions, the atmospheric 
oxygen concentration in the chamber was measured at regular 
intervals with a Beckman oxygen analyzer, to maintain the 
oxygen concentration at 8%. As well, in selected animals, 
surface temperature was monitored throughout the experi- 
ment with an electronic thermometer; surface temperature 
from the time of probe insertion remained stable (34°C) for 
the duration of hypoxic exposurc. 
Stimulated dopamine release was measured in control an- 
imals (n = 6) during the first 20 rnin following the baseline 
period. Stimulated dopamine release was also measured in 
both control (n = 6) and hypoxic (n = 7) rats during the 20- 
rnin interval following the experimental period. During stim- 
ulated release periods, the probes were perfused with 100 pg/  
ml of veratrine (Sigma) dissolved in the modified Ringer’s 
solution or that containing 100 mMK+ (5 1.2 &Na+, 100.0 
mMK+, 3.4mMCa2’,and 154.6 mMCl-,pH6.0). 
Histology 
Brains were fixed in formalin. and 12- 16 horizontal 50- 
fim-thick sections from each brain were stained with cresyl 
violet. The probe tips produced a readily identifiable anatomic 
defect. Sections were independently scored by two observers 
for symmetry and accuracy of placement; only data from rat 
pups where there was agreement between the observers were 
analyzed. The most commonly observed exclusion criteria 
were ventricular dilatation, inability to identify the placement 
sites, and placement into globus pallidus. 
Neurotransmitter and metabolite levels 
in striatal tissue 
The effect of hypoxic exposure on the postmortem striatal 
tissue content of dopamine, HVA, DOPAC, and 5-HIAA 
was also measured. Seven-day-old male Sprague-Dawley rat 
pups were placed in plastic chambers within a 34°C water 
bath and exposed to hypoxic (8% oxygen) or control condi- 
tions (n = 6/group) for 150 min. Pups were killed by decap- 
itation, and the striata were dissected out on ice, frozen, and 
stored at -70°C. 
HPLC with electrochemical detection 
Dialysate samples were analyzed within 20 rnin after col- 
lection by HPLC with electrochemical detection (HPLC-EC). 
Twenty-microliter microdialysis samples were injected di- 
rectly onto a C- 18 reverse-phase Ultrasphere column (1 5 cm 
X 4.6 mm inner diameter; 5 Fm ODS; Beckman) using a 
WISP 710 B autoinjector. The mobile phase contained 0.1 
M sodium citrate, 0.1 M sodium phosphate monobasic, 0.1 
W E D T A ,  and 22.5% methanol, adjusted to pH 3.5. Sodium 
octyl sulfate was titrated to adjust the retention time of do- 
pamine, with a final concentration of -2.15 &. Detection 
was by a glassy carbon electrode connected to an electro- 
chemical detector (LC4A Amperometric Detector; Bioan- 
alytical Systems), with a sensitivity of 1-2 nA and an electrode 
potential of 0.76 V. Detector output was recorded on a chart 
recorder, peak heights were measured, and absolute amounts 
were calculated by comparison with peak heights of standards 
included in each assay. The detection thresholds of the assay 
(defined as peak heights greater than twice baseline fluctua- 
tions) were as follows: dopamine, 36 fmol; DOPAC, 32 fmol; 
HVA, 81 fmol; and 5-HIAA, 24 fmol. Serotonin was not 
quantified in the dialysis samples. 
In preliminary experiments, we examined the stability of 
dopamine and the metabolite standards in the Ringer’s so- 
lution used for dialysis. We found that freezing and subse- 
quent thawing of samples rcduced the reliability of dopamine 
content measurements. In fresh samples, placed on ice, there 
was no deterioration in peak heights in aliquots sampled over 
several hours. To optimize the assay, all dialysis samples were 
assayed within 20 rnin after collection. 
To measure striatal tissue levels of dopamine, DOPAC, 
HVA, serotonin, and 5-HIAA, frozen striatal tissue was ho- 
mogenized in 400 p1 of perchloric acid and briefly centrifuged, 
and extracts were analyzed by the same HPLC-EC assay 
(modified after Zaczek and Coyle, 1982). 
Data analysis 
Dialysate values (mean k SEM), corrected for probe re- 
covery, are expressed as femtomoles per minute. Tissue con- 
centrations are expressed a? picomoles per microgram of wet 
tissue weight. Descriptive statistics, analyses of variance, and 
t tests were performed using a microcomputer-based statistical 
package (Systat, Evanston, IL, U.S.A.). 
RESULTS 
Microdialysis probes were implanted bilaterally be- 
cause of potential striatal dopaminergic asymmetries 
(Fig. 1). Histological examination confirmed accurate, 
symmetrical microdialysis probe placement in the 
striatum in 57% of the animals. Only data from these 
pups were included for analysis. Preliminary analysis 
of basal valucs of metabolites did not demonstrate any 
interhemispheric asymmetries. Therefore, all data pre- 
sented represent averages of the left and right sides. 
DOPAC, HVA, and 5-HIAA were detected in all 
samples. Preliminary experiments demonstrated that 
the ECF concentrations of DOPAC, HVA, and 5- 
HIAA were depressed during the first 20 rnin after in- 
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FIG. 2. Changes in striatal ECF concentrations of DOPAC iring 
hypoxic exposure in 7-day-old rats. Microdialysis sampling was 
initiated 2 h after probe insertion (see Materials and Methods), and 
samples were collected over 20-min intervals. The protocol included 
a baseline period (40 rnin), a 140-min period during which animals 
were exposed to 8% oxygen (experimental) or room air (controls), 
and a 60-min recovery period in room air. Data, corrected for probe 
recovery, are mean ? SEM (bars) values. p < 0.001 by repeated- 
measures analysis of variance. 
sertion of the microdialysis probes (DOPAC, 166.6 
& 31.2 fmol/min; HVA, 338.3 +- 59.7 fmol/min; and 
5-HIAA, 142.9 f 25.4 fmol/min; n = 6). Metabolite 
levels progressively increased over the next 100 min 
and stabilized, i.e., the change between sequential 
samples was <5%, at 120-160 min after probe inser- 
tion. Based on these preliminary observations, baseline 
sample collection was initiated after a 120-min stabi- 
lization period. 
Effects of hypoxia on ECF metabolite concentrations 
During the baseline period, ECF metabolite concen- 
trations did not significantly differ between the control 
and experimental rat pups. Baseline values (averaged 
from control and experimental animals; n = 30) were 
as follows: DOPAC, 617.2 k 33.1 fmol/min; HVA, 
974.0 2 41.5 fmol/min; and 5-HIAA, 276.0 -t 14.6 
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FIG. 3. Changes in striatal ECF concentrations of HVA during 
hypoxic exposure in 7-day-old rats. See the legend of Fig. 2 for a 
description of the experimental protocol. Data, corrected for probe 
recovery, are mean f SEM (bars) values. p < 0.001 by repeated- 
measures analysis of variance. 
0 
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FIG. Changes in striatal ECF concentrations of 5-HIAA I ring 
hypoxic exposure in 7-day-old rats. See the legend of Fig. 2 for a 
description of the experimental protocol. Data, corrected for probe 
recovery, are expressed as mean ? SEM (bars) values. p = 0.01 2 
by repeated-measures analysis of variance. 
(200 min), metabolite concentrations continued to in- 
crease in control animals to 130 rt 8% for DOPAC 
(Fig. 2), 127 * 8% for HVA (Fig. 3), and 131 & 13% 
for 5-HIAA (Fig. 4) of baseline values (n = 6). 
In contrast, hypoxia produced a marked decrease in 
the ECF concentrations of DOPAC, HVA, and 5- 
HIAA (Fig. 2-4) when compared with controls (DO- 
PAC, p < 0.001; HVA, p < 0.001; and 5-HIAA, p 
= 0.0 19; by repeated-measures analysis of variance). 
The DOPAC content declined rapidly to 48.0 f 4.4% 
of basal values within 60 rnin of hypoxia (Fig. 2 )  and 
had leveled off at 39.5 f 3.6% of baseline values by the 
end of the period of hypoxic exposure (140 min). The 
temporal pattern and magnitude of depression of HVA 
levels during hypoxia were similar to those of DOPAC 
levels; HVA concentrations fell to 44.5 +- 3.1 % of base- 
line values by the end of hypoxic exposure (Fig. 3). In 
contrast, Fig. 4 shows that ECF concentrations of 5- 
HIAA declined more slowly and to a lesser degree than 
did the levels of the dopamine metabolites during the 
period of hypoxia (to 75.5 & 5.6% of baseline). 
During the 60-min recovery period in room air, 
concentrations of both DOPAC and HVA returned 
rapidly toward control values (DOPAC, p < 0.001; 
HVA, p < 0.00 1 ; by Student's t test comparing values 
at the end of hypoxia with those at the end of the re- 
covery period). By the last sample interval, control and 
hypoxic pups did not differ significantly in their levels 
of DOPAC, but in posthypoxic pups the HVA content 
remained lower than in controls ( p  = 0.02 by Student's 
t test). In contrast, 5-HIAA concentrations in previ- 
ously hypoxic rat pups remained relatively depressed 
during the recovery period. 
Effects of hypoxia on ECF dopamine 
In the adult rat striatum, reported baseline striatal 
ECF dopamine values range from -60 to 1 10 fmol/ 
rnin (Zetterstrom et at., 1983; Westerink et al., 1984; 
Sharp et al., 1986; Robinson and Whishaw, 1988). The 
calculated threshold for detection of ECF dopamine 
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FIG. 5. Comparison of the magnitude of depolarization-evoked 
dopamine release in control and hypoxic pups. Infusion of the de- 
polarizing agents-potassium (1 00 mM) or veratrine (1 00 Fg/ml)- 
was carried out at 160-180 min (EARLY; n = 6) or at 300-320 
min (LATE; n = 6) after probe insertion in controls and after the 
conclusion of 140 min of exposure to 8% oxygen (300-320 min 
after probe insertion; n = 7) in the experimental group. p = 0.001 
by analysis of variance. 
with our assay methods was 8 fmol/min (based on a 
detection threshold of 36 fmol/2O-p1 sample and a re- 
covery efficiency of 2 1.6%). In preliminary experiments 
using 7-day-old pups, dopamine was not detected dur- 
ing the 120 rnin following probe insertion (n = 6). In 
the hypoxia group, dopamine was detected during the 
basal period in one animal (9.4 fmol/min). Dopamine 
was not detected in any of the 12 control rat pups dur- 
ing thc experimental period (160-300 min). In contrast, 
dopamine was detected, in at least one sample, in six 
of 12 rat pups during hypoxic exposure. Thus, during 
the experimental period dopamine was detected in sig- 
nificantly more animals exposed to hypoxic conditions 
than in control animals: none of 12 versus six of 12, 
respectively ( p  = 0.014 by Fisher's exact test). 
Stimulated dopamine release 
Potassium and veratrine consistently stimulated do- 
pamine accumulation in microdialysis samples (Fig. 
5). There were no differences between responses elicited 
from left and right sides or between the responses to 
these doses of potassium and veratrine. Therefore, val- 
ues from left and right striata were averaged, and values 
from potassium- and veratrine-stimulated release were 
pooled. 
In controls, the timing of the potassium or veratrine 
infusion [ 160- 180 rnin (n = 6) vs. 300-320 rnin (n 
= 6) following implantation] did not alter the magni- 
tude of dopamine release. The averaged value for de- 
polarization-evoked ECF dopamine efflux in all con- 
trols was 74.7 -t 13.9 fmol/min (n = 12). However, 
Fig. 5 shows that potassium or veratrine infusion after 
140 rnin of 8% oxygen exposure (n = 7) increased ECF 
dopamine concentrations to 344% of the control levels 
(257.1 * 32.1 fmol/min; p < 0.00 1 by analysis of vari- 
ance). No significant differences in metabolite concen- 
trations were observed between control and hypoxic 
animals during this period. 
Effects of hypoxia on tissue concentration 
of dopamine 
In striatal tissue, there were corresponding increases 
in dopamine content after hypoxia (Table 1). In pups 
killed immediately after 150 rnin of hypoxia, striatal 
dopamine concentrations were 14.70 2 0.62 pmol/mg 
of tissue, compared with 1 1.36 -t 0.94 pmol/mg of tis- 
sue in controls (Q = 0.014 by Student's t test). The 
postmortem tissue concentrations of serotonin, its me- 
tabolite 5-HIAA, and the dopamine metabolites DO- 
PAC and HVA were not altered by hypoxia (Table 1). 
DISCUSSION 
These data demonstrate that in perinatal rats ex- 
posure to moderate hypoxia produced large alterations 
in striatal catecholamine metabolism. The ECF con- 
centrations of dopamine and serotonin metabolites 
were suppressed acutely, whereas dopamine itself was 
more frequently detected in the ECF. After 2 h of hyp- 
oxia, both depolarization-evoked dopamine release and 
tissue dopamine content rose. Comparison ofthe mag- 
nitudes and temporal patterns for depression and sub- 
sequent recovery of the ECF concentrations of the do- 
pamine and serotonin metabolites indicates differential 
effects of hypoxia on these two neuronal populations. 
During exposure to hypoxia, concentrations of HVA, 
DOPAC, and 5-HIAA declined. Reduced striatal ECF 
concentrations of neurotransmitter metabolites could 
reflect changes in the production or removal of the 
metabolites or of the parent neurotransmitters (de- 
creased synthesis or release, increased uptake or re- 
moval, or both). 
The activity of the degradative enzymes monoamine 
oxidase (MAO) and catechol-0-methyl transferase may 
be limited in vivo at the level of hypoxia that was ex- 
amined, and decreased degradation rates could, in part, 
account for the observed reductions in HVA and DO- 
PAC levels. Serotonin is also metabolized by MA0 to 
5-HIAA; 5-HIAA did not show a depression in ECF 
concentrations equivalent to that of DOPAC or HVA 
TABLE 1. Effects of hypoxia on striatal concentrations 
of doDamine, serotonin, and their metabolites 
Concentration (pmol/mg of tissue) 
Compound Control Hypoxia 
Dopamine 11.36 f 0.94 14.70 k 0.62" 
DOPAC 2.26 k 0.41 1.97 f 0.3 1 
HVA 1.89 t 0.22 1.87 t 0.48 
Serotonin 0.94 * 0.04 0.97 * 0.07 
5-HIAA 0.80 k 0.08 0.66 2 0.08 
Seven-day-old male rat pups were exposed to 8% oxygen (n = 6) 
or room air (n = 6) for 150 min. Animals were then killed by de- 
capitation, and striata were quickly removed. Neurotransmitter levels 
were assayed by HPLC-EC in perchloric acid extracts. 
In animals exposed to hypoxia, tissue concentrations of dopamine 
were higher than in controls ( p  = 0.014 by t test). 
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during hypoxia, but this could conceivably reflect more 
efficient reuptake of serotonin than dopamine and the 
availability of a higher concentration of substrate for 
MAO. In contrast, more efficient removal of metabo- 
lites from the ECF is unlikely to account for the pattern 
of reduction in metabolite concentrations observed, 
because the three metabolites are carried out of the 
ECF by a common transporter. Similarly, changes in 
cerebral blood flow are unlikely to account for the de- 
creased metabolite levels. Results of two studies indi- 
cate that exposure to 8% oxygen does not augment 
cerebral blood flow in 7-day-old rats. Quantitation of 
regional cerebral perfusion by measurement of accu- 
mulation of tracer in cortex and striatum after intra- 
cardiac injection of ['4C]iodoantipyrine or [3H]flu- 
nitrazepam demonstrated no increase in tracer accu- 
mulation during hypoxia (Silverstein et al., 1984). 
Similarly, measurement of regional cerebral blood flow 
in 7-day-old rats after unilateral carotid ligation and 
exposure to 8% oxygen revealed no change in flow to 
the contralateral hemisphere during hypoxia (Vannucci 
et al., 1988). Furthermore, any increased washout of 
metabolites as a result of increased blood flow would 
be expected to affect dopamine and serotonin metab- 
olites to the same extent. 
The depolarization data provide information about 
the effects of hypoxia on dopamine itself. The increase 
in depolarization-evoked release could result from the 
intracellular translocation of dopamine to a releasable 
pool. However, the elevations in tissue dopamine levels 
indicate that total intracellular dopamine content is 
increased. These changes could reflect decreased re- 
lease, decreased intracellular degradation, increased 
synthesis, or increased reuptake of dopamine during 
hypoxia. Available data suggest that decreased dopa- 
mine release, together perhaps with decreased intra- 
cellular degradation, most likely accounts for our ob- 
servations. 
Increased reuptake of released dopamine could also 
result in intraneuronal dopamine accumulation. How- 
ever, assays of [3H]dopamine uptake in synaptosomal 
preparations from the striatum of 7-day-old rats ex- 
posed to 8% oxygen for 2 h demonstrate suppression 
of uptake (Silverstein et al., 1986). Thus, reduced reup- 
take activity may well account for the increased detec- 
tion frequency of dopamine in ECF during hypoxia 
that we observed. 
Several issues must be considered in the overall in- 
terpretation of these results in immature rodent brain. 
Benveniste et al. (1987) reported that probe insertion 
,acutely disrupts hippocampal glucose metabolism and 
blood flow in mature animals (most pronounced in the 
first 2 h) and recommended a prolonged stabilization 
period before initiation of dialysis sampling. A major 
limitation of microdialysis in immature rodents is their 
dependence on the dam for nourishment. Because pups 
cannot be returned to the dam after probe insertion, 
the inclusion of a more prolonged stabilization period 
is not feasible. In the rat pups, the baseline was rela- 
tively stable when sampling was initiated 2 h after probe 
insertion. During the course of the experiments, in 
controls, the concentrations of neurotransmitter me- 
tabolites continued to increase slowly; the factors con- 
tributing to this gradual rise are uncertain. Differences 
in the magnitudes and temporal patterns of metabolite 
suppression and the subsequent recovery between do- 
pamine metabolites and 5-HIAA were apparent. This 
specificity suggests that it is unlikely that the results 
reflect systemic derangements, e.g., temperature insta- 
bility or dehydration. However, recent studies indicate 
that small reductions in brain temperature can signif- 
icantly alter neurotransmitter release (Globus et al., 
1989). Because intracranial temperature was not mea- 
sured directly in the rat pups during hypoxic exposure, 
hypothermia cannot be excluded as a factor contrib- 
uting to the suppression of metabolite levels. 
There is considerable controversy about the accuracy 
with which ECF metabolite levels reflect the rate of 
dopamine release. Although DOPAC and HVA may 
be useful indices of central dopamine release (Roth et 
al., 1976), inconsistencies in the relationship between 
levels of dopamine and its metabolites in dialysate 
samples have been reported (Sharp et al., 1986). These 
issues have not been examined directly in the immature 
brain. Furthermore, there is no information about 
changes in the relative roles of reuptake and enzymatic 
degradation of released dopamine during development. 
In the assays of striatal tissue, no reductions in do- 
pamine or serotonin metabolite concentrations were 
observed after hypoxia. Previously, we had reported 
that HVA and 5-HIAA levels declined in striatal tissue 
during hypoxia (Silverstein and Johnston, 1984); the 
differences between the two sets of results could con- 
ceivably reflect the somewhat longer period of hypoxia 
used and the restriction to male animals in these ex- 
periments. Although tissue neurotransmitter levels 
represent the combined extra- and intraneuronal con- 
centrations, the observed discrepancy between dialysate 
and tissue levels of metabolites suggests that tissue levels 
reflect intraneuronal concentrations to a greater extent 
and that these are differences in the susceptibility to 
suppression by hypoxia of intra- and extraneuronal 
degradative enzymes. Similarly, the differences in rel- 
ative ratios of HVA and DOPAC (HVA:DOPAC ratio, 
1.58 in ECF and 0.84 in tissue) may reflect differences 
between intra- and extraneuronal metabolism. There 
is little information about developmental changes in 
dopamine catabolism. However, our observations that 
ECF levels of HVA are -50% higher than DOPAC 
levels in the 7-day-old rat, whereas in adult animals 
the ratio is reversed, suggest that maturational changes 
do occur. 
The physiologic consequences of dopamine accu- 
mulation during hypoxia may be complex. In models 
of hypoxic-ischemic brain injury in both mature and 
perinatal animals, stimulation of striatal dopamine re- 
lease acutely has been reported (Welch et al., 1978; 
Silverstein and Johnston, 1984; Brannan et al., 1987). 
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In mature animals, dopamine nerve terminals are more 
susceptible to damage than serotonin nerve terminals 
in ischemic stroke (Weinberger and Cohen, 1983). Ei- 
ther directly, or indirectly in concert with excitatory 
amino acids, dopamine release acutely, postischemic 
dopaminergic hyperactivity, or both may contribute to 
the pathogenesis of neuronal injury (Globus et al., 
1987). In 7-day-old rats that undergo right carotid ar- 
tery ligation followed by exposure to 8% oxygen for 2 
h, the time threshold for onset of dopamine release in 
striatum ipsilateral to the carotid ligation coincides 
temporally with the threshold for irreversible injury. 
Based on the data presented here, it appears likely that 
the preceding period of hypoxia may augment the re- 
leasable dopamine pool. 
Furthermore, during critical developmental periods, 
neurotransmitters may have specific trophic and reg- 
ulatory roles. Prolonged periods of moderate hypoxic 
exposure in early postnatal rats (1 2 h/day from days 2 
to 10) produce long-lasting changes in dopamine me- 
tabolism and dopamine-related behaviors (Ihle et al., 
1985; Lun et al., 1986). In the pennatal period, even 
subtle disruption of synaptic function resulting from 
transient hypoxia may have a significant impact on 
neuronal development. 
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